Combination Intensity-Modulated Radiotherapy and Sorafenib Improves Outcomes in Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis

PURPOSE: To compare the difference in outcome of hepatocellular carcinoma (HCC) with portal vein thrombosis (PVTT) between intensity-modulated radiotherapy (IMRT) concurrent with sorafenib and IMRT alone. METHODS: A total of 82 patients with PVTT from 2014 to 2019 were included. Of these, 36 receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Abulimiti, Munire, Li, Zhenyu, Wang, Haifeng, Apiziaji, Palida, Abulimiti, Yisikandaer, Tan, Yao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664501/
https://www.ncbi.nlm.nih.gov/pubmed/34899910
http://dx.doi.org/10.1155/2021/9943683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664501/
https://www.ncbi.nlm.nih.gov/pubmed/34899910
http://dx.doi.org/10.1155/2021/9943683

Ejemplares similares